Serum Lipopolysaccharide Activity Is Associated With Progression of Kidney Disease in Patients With Type 1 Diabetes
Diabetic nephropathy is one of the leading causes of death in patients with type 1 diabetes worldwide. However, whilst such renal dysfunction is often associated with a number of factors, the etiology of the complication is largely unknown. This study made use of Hycult Biotech’s LAL Chromogenic Endpoint assay (Cat.#. HIT302) to measure the serum LPS activity in 477 patients with type 1 diabetes in order to investigate whether serum LPS activity is associated with the progression of kidney disease... Read more